PFE Earnings
Upcoming earnings date and last 8 quarters of EPS surprise.
Next Earnings
EPS Surprise — Last 8 Quarters
Quarterly Detail
| Quarter | Report Date | Est EPS | Actual EPS | Surprise % | Result |
|---|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | 0.52 | 0.47 | -9.48% | Miss |
| Q4 2025 | Feb 3, 2026 | 0.57 | 0.66 | +16.18% | Beat |
| Q3 2025 | Nov 4, 2025 | 0.63 | 0.87 | +37.43% | Beat |
| Q2 2025 | Aug 5, 2025 | 0.57 | 0.78 | +35.94% | Beat |
| Q1 2025 | Apr 29, 2025 | 0.67 | 0.92 | +36.49% | Beat |
| Q4 2024 | Feb 4, 2025 | 0.46 | 0.63 | +37.20% | Beat |
| Q3 2024 | Oct 29, 2024 | 0.61 | 1.06 | +73.28% | Beat |
| Q2 2024 | Jul 30, 2024 | 0.46 | 0.60 | +30.19% | Beat |
Recent Guidance Mentions (8-K)
- May 5, 2026 · 8-K
59 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) EX-99 2 pfe-3292026xex99.htm EX-99 Document Exhibit 99 g Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance ■ Earnings Driven by Focused Execution and 22% Op Revenue Growth of Launched and Acquired Products (1) ■ Pipeline Momentum Builds on Positive Phase 3 and Mid-Sta
View 8-K filing → - May 5, 2026 · 8-K
ipeline, On Track to Start ~20 Key Pivotal Studies in 2026 NEW YORK, Tuesday, May 5, 2026 — Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2026 and reaffirmed its full-year 2026 financial guidance (2) . EXECUTIVE COMMENTARY Dr. Albert Bourla, Chairman and CEO of Pfizer: “We're off to a strong start in 2026, and it reinforces our co
View 8-K filing → - May 5, 2026 · 8-K
particularly pleased with the 22% year-over-year operational revenue growth from our launched and acquired products (1) . Today, we are reaffirming our full-year 2026 financial guidance.” OVERALL RESULTS ■ First-Quarter 2026 Revenues of $14.5 Billion, Representing 2% Year-over-Year Operational Growth – Excluding Contributions from Comirnaty and Paxlovid, Reven
View 8-K filing →
Data updated May 25, 2026 · source: Yahoo Finance via yfinance